Navigation Links
TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment

y active transdermal drug delivery technology. TransPharma aims to develop multiple drug products through strategic partnerships with leading pharmaceutical companies and through independent product development. For more information, visit the Company's website at www.transpharma-medical.com.

Contact

TransPharma Medical Ltd.
Naomi Rabbie, +972-8-915-2201 ext. 251
Marketing Manager
naomir@transpharma.co.il


'"/>




Page: 1 2 3

Related medicine technology :

1. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
2. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
5. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
6. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
7. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
8. World First Medical Treatment Announced by Researchers at Queen Mary University London and University of Leicester
9. Introgen and Clinical Collaborators to Report New Results with Advanced-Stage Cancer Therapies at Upcoming Medical Meetings
10. Limiting Eligibility for Medical Studies Can Omit Women, African-Americans, Stanford Study Finds
11. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
Post Your Comments:
(Date:12/4/2009)... ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) announced ... allowed its patent application on a system for automation ... Company,s DCVax® therapeutic cancer vaccines. These initial manufacturing ... dendritic cells (which are the critical ingredient) in the ...
(Date:12/3/2009)... Medical Systems, a subsidiary of Hill-Rom Holdings, Inc. (NYSE: ... its new Allen Amatech(TM) OEM (Original Equipment Manufacturer) business ... website reinforces the Allen Amatech(TM) brand identity and includes ... detailed descriptions and design specifications for the products. "We ...
(Date:12/3/2009)... Ted Karkus, Chairman and CEO of The Quigley Corporation, ... that the Company has completed its evaluation of its ... has concluded that it is in its best interests ... may include but are not limited to its Cold-EEZE® ...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3New iPhone App Outbreaks Near Me Locates H1N1 28Swine Flu 29 Infectious Diseases 55885 1New iPhone App Outbreaks Near Me Locates H1N1 28Swine Flu 29 Infectious Diseases 55885 2New iPhone App Outbreaks Near Me Locates H1N1 28Swine Flu 29 Infectious Diseases 55885 3Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 1Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 2Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 3Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 4HeartWare International Inc Temporary Suspension of Trading 13774 1HeartWare International Inc Temporary Suspension of Trading 13774 2HeartWare International Inc Temporary Suspension of Trading 13774 3
... SAN MATEO, Calif., July 11 NeurogesX, Inc.,(Nasdaq: ... developing and,commercializing novel pain management therapies, announced the ... of NGX-1998. The product,candidate is a high-concentration, capsaicin-based ... directly to the pain site., The randomized, ...
... MEDX ) today provided a detailed overview ... antibody development, and the,multiple opportunities Medarex is engaged ... on current and future antibody programs,as well as ... and CEO, Howard H. Pien, and other members ...
Other Medicine Technology:NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation 2NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation 3NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation 4Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 2Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 3Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 4Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 5Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 6
(Date:12/5/2009)... 5 There have been significant scientific advances in ... to gain a better understanding of how certain diseases ... provide patients with the best care. Research presented today ... of Hematology explores optimal induction therapies for managing multiple ...
(Date:12/5/2009)... CAPE TOWN, South Africa, December 5 The ... outskirts of Cape Town opened its doors,today (5 ... joined by,Western Cape Premier Helen Zille, 2010 FIFA ... Jordaan, South African Football Association,President Kirsten Nematandani and ...
(Date:12/5/2009)... NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative ... Research presented today at the 51st Annual Meeting ... new treatment options and improved diagnostic methods for ... leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that ...
(Date:12/5/2009)... myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the ... tying the knot, since research has shown that never-married adults ... there something wrong with those who go it alone anyway? ... psychological measures shows that never-married people aged 40 and up ...
(Date:12/5/2009)... new international private medical insurance plan which follows the acclaimed modular ... flexibility to add or remove a wide range of options to ... their benefits to complement those already offered in their country of ... ...
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:AVIVA's Private Health Insurance Products Solutions Go International 2
... March 19 NHS Choices ( http://www.nhs.uk ), ... new Good Food package aimed to,help people achieve ... improved,knowledge of the nutritional content of the food ... the Live Well package,( http://www.nhs.uk/Livewell/loseweight/Pages/Goodfoodhomehome.aspx ) enables,users to ...
... 19 Digirad Corporation,(Nasdaq: DRAD ), ... products,and services to physicians, offices, hospitals and ... has appointed veteran healthcare executive,John W. Sayward ... Mr. Sayward, 56, has more than 30 ...
... the HIV/AIDS epidemic increases food insecurity in African cities ... chances of this happening is the focus of a ... and Southern African expertise will be used in developing ... crucial issue. , Funded by the Canadian International Development ...
... of California,s Quality-in-Sights ... Hospital Incentive Program, THOUSAND ... Cross) today announced the introduction of its,Quality-in-Sights Hospital Incentive Program ... financial incentives with quality,improvements. It uses select indicators that have ...
... to drug-resistant bacteria, CDC study finds , , WEDNESDAY, March ... Staphylococcus aureas bacterium and caught outside of the ... States than previously believed, preliminary research suggests. , "Over ... of a severe CAP [community-acquired pneumonia] caused by ...
... Texas, Struggling Medicaid,Program, AUSTIN, Texas, March 19 ... proposed budget and regulatory,changes that will cut Medicare-financed nursing ... ahead - the 4th highest level of cuts in ... per day - national,and state long term care leaders ...
Other Medicine News:Health News:Digirad Corporation Appoints John W. Sayward to Its Board of Directors 2Health News:Digirad Corporation Appoints John W. Sayward to Its Board of Directors 3Health News:Digirad Corporation Appoints John W. Sayward to Its Board of Directors 4Health News:Food insecurity linked with HIV/AIDS in Africa 2Health News:Blue Cross of California Introduces Pay-for-Performance Hospital Program 2Health News:Community-Based Staph Pneumonia More Common Than Thought 2Health News:New Analysis of Bush FY 2009 Budget: Texas Medicare Cuts 4th Highest in Nation 2Health News:New Analysis of Bush FY 2009 Budget: Texas Medicare Cuts 4th Highest in Nation 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: